Adalimumab-Receiving Ulcerative Colitis Patient Suffered Latent Tuberculosis Reactivation Despite Correct Chemoprophylaxis and was Successfully Treated while on Anti-Tumour Necrosis Factor Therapy.
作者信息
Agudo Belén, Díaz Gema, González-Lama Yago
机构信息
Department of Gastroenterology and Hepatology, Puerta de Hierro University Hospital, Madrid, Spain.
Department of Pneumology, Puerta de Hierro University Hospital, Madrid, Spain.
出版信息
J Crohns Colitis. 2016 Dec;10(12):1453-1454. doi: 10.1093/ecco-jcc/jjw110. Epub 2016 May 23.
PMID:27215554
Abstract
摘要
Zotero 插件